Seelos Therapeutics Doses First Patient in a Registrational Phase II/III study of SLS-005 in Spinocerebellar Ataxia
Seelos will also present at the International Congress for Ataxia Research in November NEW YORK, Oct. 25, 2022 /PRNewswire/ -- Seelos Therapeuti...
Source: businessinsider.com